Funding
← Back to your selection

Breyer Capital

Activity from announced rounds

Activity in this selectionOct 18, 2026 · Jul 21, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$185M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Undisclosed1

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B
Participant
Network Bio

Builds AI models trained on patient tissue and clinical data for disease diagnostics

$50MStrategic
Role not disclosed